Hims & Hers continues to spend heavily on marketing to attract new customers. During the quarter, its marketing spending jumped 50% to nearly $218 million. Marketing expenses took up 40% of revenue in ...

Aug 5 - Hims & Hers Health shares took a hit on Tuesday, dropping more than 10% in early trading. The telehealth company ...

Hims Hers Health Inc.公布了2025年第二季度财报，每股收益(EPS)表现亮眼。公司报告的每股收益为$0.17，超过预期的$0.15，惊喜度达13.33%。然而，收入略低于预期，为$544.8百万，而预测为$549.87百万。尽管如此，该股票在市场上反应积极，常规交易时段上涨1.31%，盘后交易进一步上涨1.49%。 Hims Hers Health在2025年第二季度展示了强 ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Telehealth company Hims & Hers Health (NYSE:HIMS) fell short of the market’s revenue expectations in Q2 CY2025, but sales ...

英为财情Investing.com - Hims Hers Health (NYSE: HIMS )星期一发布了第二季度的财报，数据显示，公司营收逊于分析师的预期，每股收益超出了分析师的预期。 在该公司发布的最新财报中，公司每股收益为$0.17，总营收为$544.8M，而此前英为财情Investing.com对分析师的调查显示，分析师预期该公司的营收为$549.87M，每股收益为$0.15.

Hims & Hers stock dropped a sharp 11% after the company missed Q2 2025 revenue estimates, raising concerns about its booming ...

Hims & Hers Health showed a sharper-than-expected revenue hiccup in Q2, sending the stock down. Click here to find out why ...

Shares of Hims & Hers Health fell 13.5% in after-hours trading Monday after the telehealth company missed Wall Street’s ...

Hims & Hers Health is upgraded to a speculative Buy after a 20% drop, with growth potential in GLP-1 sales outweighing key ...

Hims & Hers Health (HIMS) stock falls after reporting lower Q2 revenues. Analysts caution about near-term challenges, ...